Highlight Report: Cell Type Selection for Toxicity Testing

Overview

Journal EXCLI J

Specialty Biology

Date 2019 Feb 5

PMID 30713478

Authors

H M Bolt

Affiliations

Soon will be listed here.

References

Pikkarainen S, Tokola H, Kerkela R, Ruskoaho H . GATA transcription factors in the developing and adult heart. Cardiovasc Res. 2004; 63(2):196-207. DOI: 10.1016/j.cardiores.2004.03.025. View

Rysa J, Tenhunen O, Serpi R, Soini Y, Nemer M, Leskinen H . GATA-4 is an angiogenic survival factor of the infarcted heart. Circ Heart Fail. 2010; 3(3):440-50. DOI: 10.1161/CIRCHEARTFAILURE.109.889642. View

Kikuchi K, Holdway J, Werdich A, Anderson R, Fang Y, Egnaczyk G . Primary contribution to zebrafish heart regeneration by gata4(+) cardiomyocytes. Nature. 2010; 464(7288):601-5. PMC: 3040215. DOI: 10.1038/nature08804. View

Krug A, Kolde R, Gaspar J, Rempel E, Balmer N, Meganathan K . Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2012; 87(1):123-43. PMC: 3535399. DOI: 10.1007/s00204-012-0967-3. View

Gupta V, Gemberling M, Karra R, Rosenfeld G, Evans T, Poss K . An injury-responsive gata4 program shapes the zebrafish cardiac ventricle. Curr Biol. 2013; 23(13):1221-7. PMC: 3759223. DOI: 10.1016/j.cub.2013.05.028. View

Godoy P, Hewitt N, Albrecht U, Andersen M, Ansari N, Bhattacharya S . Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol. 2013; 87(8):1315-530. PMC: 3753504. DOI: 10.1007/s00204-013-1078-5. View

Waldmann T, Rempel E, Balmer N, Konig A, Kolde R, Gaspar J . Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014; 27(3):408-20. PMC: 3958134. DOI: 10.1021/tx400402j. View

Weng M, Natarajan K, Scholz D, Ivanova V, Sachinidis A, Hengstler J . Lineage-specific regulation of epigenetic modifier genes in human liver and brain. PLoS One. 2014; 9(7):e102035. PMC: 4108363. DOI: 10.1371/journal.pone.0102035. View

Meganathan K, Jagtap S, Srinivasan S, Wagh V, Hescheler J, Hengstler J . Neuronal developmental gene and miRNA signatures induced by histone deacetylase inhibitors in human embryonic stem cells. Cell Death Dis. 2015; 6:e1756. PMC: 4669700. DOI: 10.1038/cddis.2015.121. View

10.

Rempel E, Hoelting L, Waldmann T, Balmer N, Schildknecht S, Grinberg M . A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015; 89(9):1599-618. PMC: 4551554. DOI: 10.1007/s00204-015-1573-y. View

11.

Sampaio S, Branco A, Wojtala A, Vega-Naredo I, Wieckowski M, Oliveira P . p66Shc signaling is involved in stress responses elicited by anthracycline treatment of rat cardiomyoblasts. Arch Toxicol. 2015; 90(7):1669-84. DOI: 10.1007/s00204-015-1583-9. View

12.

Chaudhari U, Nemade H, Wagh V, Gaspar J, Ellis J, Srinivasan S . Identification of genomic biomarkers for anthracycline-induced cardiotoxicity in human iPSC-derived cardiomyocytes: an in vitro repeated exposure toxicity approach for safety assessment. Arch Toxicol. 2015; 90(11):2763-2777. PMC: 5065579. DOI: 10.1007/s00204-015-1623-5. View

13.

Pallocca G, Grinberg M, Henry M, Frickey T, Hengstler J, Waldmann T . Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2015; 90(1):159-80. PMC: 4710658. DOI: 10.1007/s00204-015-1658-7. View

14.

Chaudhari U, Nemade H, Gaspar J, Hescheler J, Hengstler J, Sachinidis A . MicroRNAs as early toxicity signatures of doxorubicin in human-induced pluripotent stem cell-derived cardiomyocytes. Arch Toxicol. 2016; 90(12):3087-3098. PMC: 5104806. DOI: 10.1007/s00204-016-1668-0. View

15.

Shinde V, Hoelting L, Srinivasan S, Meisig J, Meganathan K, Jagtap S . Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Tox and STOP-Tox tests. Arch Toxicol. 2016; 91(2):839-864. PMC: 5306084. DOI: 10.1007/s00204-016-1741-8. View

16.

Godoy P, Widera A, Schmidt-Heck W, Campos G, Meyer C, Cadenas C . Gene network activity in cultivated primary hepatocytes is highly similar to diseased mammalian liver tissue. Arch Toxicol. 2016; 90(10):2513-29. PMC: 5043005. DOI: 10.1007/s00204-016-1761-4. View

17.

Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou S . Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol. 2017; 91(11):3477-3505. DOI: 10.1007/s00204-017-2045-3. View

18.

Godoy P, Schmidt-Heck W, Hellwig B, Nell P, Feuerborn D, Rahnenfuhrer J . Assessment of stem cell differentiation based on genome-wide expression profiles. Philos Trans R Soc Lond B Biol Sci. 2018; 373(1750). PMC: 5974444. DOI: 10.1098/rstb.2017.0221. View

19.

Karhu S, Valimaki M, Jumppanen M, Kinnunen S, Pohjolainen L, Leigh R . Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds. Arch Toxicol. 2018; 92(9):2897-2911. PMC: 6132687. DOI: 10.1007/s00204-018-2257-1. View